Expert Theaters

All Expert Theaters are non-CME, industry-presented educational. During each session, food and beverages appropriate for the time slot will be served. Sessions in the exhibit hall are limited to 100 participants and those outside the hall are limited to 40 participants; seating is first-come, first-served.

Incorporation of POC hs-cTnI in the ED for the management of suspected ACS

In this presentation we will briefly review the history of biomarkers used for the diagnosis of AMI. We will then focus on the advantages of hs-cTn over contemporary troponins and the role of POC tes...

Thinking Outside the Box: How to Help ABSSSI Patients Avoid Hospitalization

Join us to learn more about an antibiotic option that may help your patients with ABSSSI avoid hospitalization.

Built for Complexity: Scaling Ambient AI in the ED

Sunday, September 7 Presented by: Ambience Healthcare Speakers: Will Morris, MD, MBA, Chief Medical Officer, Ambience Healthcare Emergency Physician Leader at Large Health System - TBD Time: 2:30pm – ...

Reimagining Epinephrine Administration with Epinephrine Nasal Spray

This session explores the emerging role of needle-free epinephrine nasal spray as a novel approach for intervention in situations where rapid epinephrine administration is needed.

Blood-Based Biomarkers for Mild Traumatic Brain Injury: How and Why We Implemented Them at Our

Each year, an estimated 2.8–4.8 million Americans are diagnosed with traumatic brain injury1,2. The vast majority of these presentations will be characterized as mild.

Expert Perspectives on Diagnostic Decision-Making for Acute Infections in the ED

When patients present to the emergency department with signs of acute infection, the challenge lies not only in identifying the cause quickly and accurately but also in managing the ever-present fear ...

From Screening to Care: Unlocking the Benefits of Life-Saving Routine Bloodborne Screening in Emergency Medicine

Routine, EHR-driven screening for HIV, HCV (Hepatitis C Virus), and HBV (Hepatitis B Virus) in Emergency Departments (EDs) across the United States is increasingly recognized as a critical public heal...

An Opioid Overdose Medicine for the Challenges of Today

Take a journey through the timeline of the opioid epidemic, outlining key events and milestones in an evolving crisis. Statistics outline the severity of a crisis fueled by fentanyl, driving the need ...

TriVerity: Leveraging the Patient Immune Response to Rapidly Diagnose Patients Suspected of Acute Infection and Prediction of All Cause ICU Admission in the Emergency Room

Learn how clinicians are transforming emergency care through a ~30 minute blood test.

Being Prepared for All Rabies Exposures

Monday, September 8 Presented by: Kedrion Biopharma, Inc. Speaker: Edward R. Rensimer, MD, FACP Time: 2:30pm – 3:15pm Location: Exhibit Hall, Expert Theater 1 Kedrion Biopharma is proud to partner wit...

Evidence-Based Treatment of Recurrent Pericarditis

Approximately 40,000 individuals in the United States seek care for recurrent pericarditis (RP) annually. While typically not life-threatening, RP is often associated with sharp pain at each episode a...

Ensuring Continuity of Care in Hepatic Encephalopathy

Join us for a discussion regarding ways to enhance care for hospitalized patients with hepatic encephalopathy (HE). We will review strategies for optimizing the continuum of care for patients with HE ...

Decrease Diagnostic Uncertainty in At-risk Patients Using PCT

At-risk patients often present with nonspecific symptoms such as shortness of breath, making their diagnosis challenging. Rapid and accurate diagnoses are of utmost importance.